Clamping device with pivoting retainer
US-12471221-B2 · Nov 11, 2025 · US
This page is not indexed by search engines while we improve data quality.
O'Brien Christopher patents
O'Brien Christopher is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | O'Brien Christopher |
| Total patents | 22 |
| First publication | Jul 12, 2016 |
| Latest publication | Nov 11, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Method of treating ulcerative colitis with an antibody to IL-23
US-2025236664-A1 · Jul 24, 2025 · US
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
US-2025171530-A1 · May 29, 2025 · US
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
US-12258393-B2 · Mar 25, 2025 · US
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
US-2024294625-A1 · Sep 5, 2024 · US
Clamping device with pivoting retainer
US-2024237226-A9 · Jul 11, 2024 · US
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
US-2024182557-A1 · Jun 6, 2024 · US
Clamping device with pivoting retainer
US-2024138073-A1 · Apr 25, 2024 · US
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
US-2024010718-A1 · Jan 11, 2024 · US
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
US-2024002494-A1 · Jan 4, 2024 · US
Recent patents
Latest publications not already listed above.
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
US-11780911-B2 · Oct 10, 2023 · US
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
US-2022372129-A1 · Nov 24, 2022 · US
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
US-2021363234-A1 · Nov 25, 2021 · US
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
US-2021253690-A1 · Aug 19, 2021 · US
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
US-2021171622-A1 · Jun 10, 2021 · US
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
US-2021115129-A1 · Apr 22, 2021 · US
Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody
US-10961307-B2 · Mar 30, 2021 · US
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
US-2020369761-A1 · Nov 26, 2020 · US
Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
US-2020095315-A1 · Mar 26, 2020 · US
Use of reslizumab to treat moderate to severe eosinophilic asthma
US-10577414-B2 · Mar 3, 2020 · US
Use of reslizumab to treat moderate to severe eosinophilic asthma
US-9815894-B2 · Nov 14, 2017 · US
Method, system, and apparatus for preparing substrates and bonding semiconductor layers to substrates
US-9390942-B2 · Jul 12, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Janssen Biotech Inc | 16 |
| Raytheon Co | 3 |
| Cephalon Inc | 2 |
| O'Brien Christopher | 1 |
| Zangrilli James | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/244 | 18 |
| A61K2039/545 | 18 |
| A61K2039/505 | 18 |
| A61P1/04 | 16 |
| C07K2317/565 | 15 |